Litcius/Paper detail

Galectins in epithelial-mesenchymal transition: roles and mechanisms contributing to tissue repair, fibrosis and cancer metastasis

Elisa Pérez-Moreno, Claudia Oyanadel, Adely de la Peña, Ronny Hernández, Francisca Pérez-Molina, Claudia Metz, Alfonso González, Andrea Soza

2024Biological Research20 citationsDOIOpen Access PDF

Abstract

Galectins are soluble glycan-binding proteins that interact with a wide range of glycoproteins and glycolipids and modulate a broad spectrum of physiological and pathological processes. The expression and subcellular localization of different galectins vary among tissues and cell types and change during processes of tissue repair, fibrosis and cancer where epithelial cells loss differentiation while acquiring migratory mesenchymal phenotypes. The epithelial-mesenchymal transition (EMT) that occurs in the context of these processes can include modifications of glycosylation patterns of glycolipids and glycoproteins affecting their interactions with galectins. Moreover, overexpression of certain galectins has been involved in the development and different outcomes of EMT. This review focuses on the roles and mechanisms of Galectin-1 (Gal-1), Gal-3, Gal-4, Gal-7 and Gal-8, which have been involved in physiologic and pathogenic EMT contexts.

Topics & Concepts

GalectinEpithelial–mesenchymal transitionBiologyCell biologyMesenchymal stem cellGlycoproteinGlycanGalectin-1GlycosylationGalectin-3GlycolipidMetastasisContext (archaeology)CancerCancer researchImmunologyBiochemistryGeneticsPaleontologyGalectins and Cancer BiologyGlycosylation and Glycoproteins ResearchSignaling Pathways in Disease
Galectins in epithelial-mesenchymal transition: roles and mechanisms contributing to tissue repair, fibrosis and cancer metastasis | Litcius